Showing results (201-210 of 243) with videos related to

Sort By:
Pageof 25
European Journal of Cancer & Clinical Oncology|November 1, 1988
Epidermal growth factor receptor in human breast cancer: correlation with steroid hormone receptors and axillary lymph node involvementF Battaglia, G Scambia, S Rossi, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 1, 1994
Biochemical and pharmacological characterization of the cyclooxygenase activity of human blood prostaglandin endoperoxide synthasesP Patrignani, M R Panara, A Greco, et al.
Medicinal Chemistry (Shariqah (United Arab Emirates))|June 22, 2006
Immunohistochemical and serological 90K/Mac-2BP detection in hepatocellular carcinoma patients: different behaviour of two monoclonal antibodiesA M Valentini, P A Iacovazzi, M Correale, et al.
Circulation|April 7, 1998
Increased levels of soluble P-selectin in hypercholesterolemic patientsG Davì, M Romano, A Mezzetti, et al.
Anticancer Research|May 16, 2000
Chronomodulated infusion of cisplatin, 5-fluorouracil and folinic acid: lack of activity in advanced colorectal cancerC Natoli, M T Scognamiglio, M T Martino, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
Oxaliplatin activity against metastatic colorectal cancer. A phase II study of 5-day continuous venous infusion at circadian rhythm modulated rateF Levi, B Perpoint, C Garufi, et al.
Cancer|February 15, 1993
DNA and S-phase fraction analysis by flow cytometry in prostate cancer. Clinicopathologic implicationsN Tinari, C Natoli, D Angelucci, et al.
American Journal of Clinical Oncology|February 1, 1995
A phase I study of recombinant interferon-alpha administered as a seven-day continuous venous infusion at circadian-rhythm modulated rate in patients with cancerS Iacobelli, C Garufi, L Irtelli, et al.
Cancer|March 15, 1990
Recombinant alpha-2b-interferon enhances the circulating levels of a 90-kilodalton (K) tumor-associated antigen in patients with gynecologic and breast malignanciesG Scambia, P B Panici, S Iacobelli, et al.
International Journal of Cancer|April 21, 1995
Expression of tumor-associated 90K-antigen in human breast cancer: no correlation with prognosis and response to first-line therapy with tamoxifenJ A Foekens, J G Klijn, C Natoli, et al.
Pageof 25